KK
SUPN icon

KLP Kapitalforvaltning’s Supernus Pharmaceuticals SUPN Stock Holding History

KLP Kapitalforvaltning’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$586K Hold
12,600
– – ﹤0.01% 1441
2026
Q1 		$651K Buy
12,600
+600
+5% +$30.6K ﹤0.01% 1283
2025
Q4 		$596K Sell
12,000
-22,600
-65% -$1.1M ﹤0.01% 1320
2025
Q3 		$1.65M Sell
34,600
-7,100
-17% -$286K 0.01% 769
2025
Q2 		$1.31M Hold
41,700
– – 0.01% 839
2025
Q1 		$1.37M Hold
41,700
– – 0.01% 795
2024
Q4 		$1.51M Buy
+41,700
New +$1.47M 0.01% 789

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

KLP Kapitalforvaltning's SUPN Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 12,600 shares worth $586K. The position accounts for ﹤0.01% of the portfolio, ranked #1441.

KLP Kapitalforvaltning first reported a position in SUPN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.65M in Q3 2025. 332 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • KLP Kapitalforvaltning held 12,600 shares of Supernus Pharmaceuticals worth $586K as of Q2 2026.
  • KLP Kapitalforvaltning left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1441 holding.
  • KLP Kapitalforvaltning first reported a position in Supernus Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Supernus Pharmaceuticals position peaked at $1.65M in Q3 2025.
  • 332 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.